Expert profile

Dr. Avindra Nath

Neurologist and neuroinflammation researcher

Neuroinflammation • neuro-immunology • Long COVID • ME/CFS • viral neurological complications

1Discussion
69 minAnalysed
Last reviewed: Jun 8, 2026·Credential: MD; Clinical Director, NIH National Institute of Neurological Disorders and Stroke (NINDS); leading US researcher on Long COVID and post-viral neurological illness.·First indexed: Jun 8, 2026

About the expert

Focus: Neuroinflammation and post-viral neurological complications

Clinical Director of the National Institute of Neurological Disorders and Stroke (NIH NINDS). One of the leading US researchers on neurological complications of viral infections, including Long COVID, ME/CFS, and post-infectious neurological syndromes. His work focuses on persistent viral remnants, immune exhaustion, vascular damage, and neuroinflammation as drivers of post-viral illness.

Expert discussions with Dr. Avindra Nath

Putrino + Nath: A vagus nerve stimulation trial result and the case for combination therapy in Long COVID
A randomized controlled trial of vagus nerve stimulation (VNS) for Long COVID missed its primary endpoint, but physiological data suggests higher doses or combination with medications like famotidine may still help some patients with autonomic dysfunction. Persistent viral remnants and immune exhaustion appear to drive vascular damage and brain inflammation in many cases. The complexity of Long COVID likely requires personalized combination therapies rather than a single cure.